Using a single-case methodology, 10 women (mean age = 45 y/o) with chronic insomnia and GAD were randomly assigned to 1 of 2 groups: (1) CBT for GAD followed by CBT for insomnia, or (2) CBT for insomnia followed by CBT for GAD. The gene discussed is GAD1; the disease is insomnia measurement.